Pierre Fabre Laboratories

Pierre Fabre Laboratories is a leading French healthcare and beauty company with over 40 years of experience in the innovation, development, manufacturing, and commercialization of oncology treatments. In 2022, the company allocated approximately 80% of its R&D expenditure to oncology and announced targeted therapies as its primary R&D focus. Its current commercial portfolio in oncology covers colorectal cancer, breast cancer, lung cancer, melanoma, hematology, and precancerous skin conditions such as actinic keratosis.